Literature DB >> 19949479

Cardiac resynchronisation therapy and the role of optimal device utilisation.

S Buck1, A H Maass, D J van Veldhuisen, I C Van Gelder.   

Abstract

Despite established selection criteria, 30 to 40% of patients do not respond to cardiac resynchronisation therapy. By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17:354-7.).

Entities:  

Year:  2009        PMID： 19949479      PMCID： PMC2758352          DOI： 10.1007/BF03086283

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  16 in total

1.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

2.  Importance of heart rate during exercise for response to cardiac resynchronization therapy.

Authors:  Alexander H Maass; Sandra Buck; Wybe Nieuwland; Johan Brügemann; Dirk J van Veldhuisen; Isabelle C Van Gelder
Journal:  J Cardiovasc Electrophysiol       Date:  2009-02-02

3.  Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.

Authors:  Claudia Ypenburg; Rutger J van Bommel; Victoria Delgado; Sjoerd A Mollema; Gabe B Bleeker; Eric Boersma; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2008-10-21       Impact factor: 24.094

Review 4.  Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study.

Authors:  S Ellery; T Pakrashi; V Paul; S Sack
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

5.  Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy.

Authors:  Navinder S Sawhney; Alan D Waggoner; Sanjeev Garhwal; Mohit K Chawla; Judy Osborn; Mitchell N Faddis
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

Review 6.  Cardiac resynchronization therapy in congestive heart failure: Ready for prime time?

Authors:  Antonis S Manolis
Journal:  Heart Rhythm       Date:  2004-09       Impact factor: 6.343

7.  Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation.

Authors:  K Khadjooi; P W Foley; S Chalil; J Anthony; R E A Smith; M P Frenneaux; F Leyva
Journal:  Heart       Date:  2008-01-20       Impact factor: 5.994

8.  Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.

Authors:  Sandra Buck; Michiel Rienstra; Alexander H Maass; Wybe Nieuwland; Dirk J Van Veldhuisen; Isabelle C Van Gelder
Journal:  Europace       Date:  2008-03-20       Impact factor: 5.214

9.  Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation.

Authors:  Renato Pietro Ricci; Loredana Morichelli; Massimo Santini
Journal:  Europace       Date:  2008-11-16       Impact factor: 5.214

10.  Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.

Authors:  C Jan Willem Borleffs; Claudia Ypenburg; Rutger J van Bommel; Victoria Delgado; Lieselot van Erven; Martin J Schalij; Jeroen J Bax
Journal:  Heart Rhythm       Date:  2008-12-13       Impact factor: 6.343
View more
  6 in total

1.  Cardiac resynchronisation therapy and the role of optimal device utilisation.

Authors:  S Buck; A H Maass; D J van Veldhuisen; I C Van Gelder
Journal:  Neth Heart J       Date:  2009-09       Impact factor: 2.380

2.  Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism.

Authors:  E E van der Wall; M J Schalij; A van der Laarse; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-12       Impact factor: 2.357

3.  Evidence of scar tissue: contra-indication to cardiac resynchronization therapy?

Authors:  E E van der Wall; M J Schalij; H F Verwey; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-08       Impact factor: 2.357

4.  Cardiac resynchronization in mild heart failure: all issues resolved? Editorial to "Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis of randomized controlled trials" by Ronghui Tu et al.

Authors:  Alexander H Maass
Journal:  Cardiovasc Drugs Ther       Date:  2011-08       Impact factor: 3.727

5.  Cardiovascular Magnetic Resonance Imaging-Incremental Value in a Series of 361 Patients Demonstrating Cost Savings and Clinical Benefits: An Outcome-Based Study.

Authors:  Vinayak A Hegde; Robert Ww Biederman; J Ronald Mikolich
Journal:  Clin Med Insights Cardiol       Date:  2017-05-19

6.  Cardiac resynchronization therapy; evaluation by advanced imaging techniques.

Authors:  E E van der Wall; M J Schalij; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-29       Impact factor: 2.357
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.